CEO & Founder
at electronRx
Dr. Bipin Patel is the CEO and founder of electronRx, a deep tech start-up based in Cambridge, UK, developing novel chronic disease and hospital patient management solutions. Dr. Patel is an entrepreneur with over 20 years of experience in medical engineering, drug development and commercialization. He has been chief scientific officer, chief business development officer, drug development director, board director, chairman and CEO in numerous biotech companies, and has also held leadership positions in big pharma including Pierre Fabre, Merck KGaA and GSK. He studied biochemistry and pharmacology at the University of Southampton before completing his master's and PhD in medical engineering at the University of Strathclyde and UCL, respectively. He has since become a named inventor on over ten patent families in and around medical devices and has taken oncology drug-device combinations from molecule to market in the US and Japan. Due to this rare and privileged insight into not only the technological R&D and innovation spheres but also clinical practice and pharma drug and business development, Dr. Patel is a key digital health thought leader working on the frontlines of deep tech innovation in healthcare. Dr. Patel’s admiration for the endless complexity of human physiology and his real-life experience of the limitations of generalized pharmacological medicine inspired the creation of electronRx. The team’s mission is to build the interface between technology, the human body and healthcare organizations that will usher in a new therapeutic paradigm of personalized digital medicine, transforming how we deliver healthcare and treat disease.
